Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food, and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride, and Xprecia Prime, which are medical devices; Sentia non-medical wine testing products, and Petrackr, which is a blood glucose test used in cats and dogs. It has one reportable segment: a specialist biosensors company. Geographically, the company generates the majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
76
Stocks News & Analysis
stocks
SpaceX rally continues, expanding sky-high valuations
stocks
This US AI champion’s stock is too cheap to ignore
stocks
Why SpaceX is coming to your Super Fund
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,030.00 | 43.20 | -0.48% |
| CAC 40 | 8,467.98 | 37.19 | 0.44% |
| DAX 40 | 25,026.80 | 92.13 | 0.37% |
| Dow JONES (US) | 51,564.70 | 72.15 | 0.14% |
| FTSE 100 | 10,399.70 | 108.91 | -1.04% |
| HKSE | 23,924.81 | 387.35 | -1.59% |
| NASDAQ | 26,517.93 | 496.28 | 1.91% |
| Nikkei 225 | 71,109.13 | 55.64 | 0.08% |
| NZX 50 Index | 13,433.08 | 69.77 | 0.52% |
| S&P 500 | 7,500.58 | 80.48 | 1.08% |
| S&P/ASX 200 | 8,814.20 | 42.40 | -0.48% |
| SSE Composite Index | 4,090.48 | 17.59 | -0.43% |